Achievements
- Bristol-Myers Squibb “Freedom to Discover Award”
- the ASBMB-Avanti Award in Lipids, the Roy Greep Award for outstanding research of the Endocrine Society
- the ASBMB-Merck Award for outstanding research (shared with Dr. Walther).
- Election to American Society for Clinical Investigation, the Association of American Physicians, and Fellow of the American Society for Cell Biology
View a full listing of Robert Farese’s journal articles.
Disclosures
Members of the MSK Community often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community. These activities outside of MSK further our mission, provide productive collaborations, and promote the practical application of scientific discoveries.
MSK requires doctors, faculty members, and leaders to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public. Not all disclosed interests and relationships present conflicts of interest. MSK reviews all disclosed interests and relationships to assess whether a conflict of interest exists and whether formal COI management is needed.
Robert Farese discloses the following relationships and financial interests:
-
Bluefield Project to Cure FTD
Fiduciary Role / Position; Professional Services and Activities (Uncompensated) -
FTD Frontiers Neuroscience
Fiduciary Role / Position; Professional Services and Activities (Uncompensated) -
Gladstone Institutes
Intellectual Property Rights
-
NYU School of Medicine
Professional Services and Activities -
Triglyceride Forum
Professional Services and Activities
The information published here is a complement to other publicly reported data and is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.
This page and data include information for a specific MSK annual disclosure period (January 1, 2024 through disclosure submission in spring 2025). This data reflects interests that may or may not still exist. This data is updated annually.
Learn more about MSK’s COI policies here. For questions regarding MSK’s COI-related policies and procedures, email MSK’s Compliance Office at ecoi@mskcc.org.
View all disclosures